Document is current
Any future updates will be listed below
-
Authors
Offin, Michael https://orcid.org/0000-0002-7959-3018
Aguirre, Nicole
Yang, Soo Ryum
Sauter, Jennifer L.
Karagkounis, Georgios
Mohamed, Mostafa
Cercek, Andrea
Kundra, Ritika
Zhang, Yanming
Wang, Hui Mei
Morris, Marty P.
Ladanyi, Marc
Nash, Garrett M.
Zauderer, Marjorie G.
-
Funding
Funding for this research was provided by:
NIH/NCI (P30 CA008748)
- License Information
-
More Information
Article History
Received: 30 May 2024
Accepted: 25 July 2024
First Online: 21 August 2024
Disclosure
: MDO reports consulting roles/honorarium with Novartis, Jazz, Pfizer, Targeted Oncology, OncLive, American Society for Radiation Oncology. Grant support from the Druckenmiller Foundation and LUNGevity Foundation. Uncompensated scientific advisory board member for the Mesothelioma Applied Research Foundation. NA reports no pertinent disclosures. SRY reports consulting roles/honorarium with AstraZeneca, Sanofi, Amgen, AbbVie, Roche, Medscape, Medical Learning Institute, PRIME Education. JLS reports no pertinent disclosures. GK reports no pertinent disclosures. MM reports no pertinent disclosures. AC reports no pertinent disclosures. RK reports no pertinent disclosures. YZ reports no pertinent disclosures. HMW reports no pertinent disclosures. MPM reports no pertinent disclosures. ML reports no pertinent disclosures. GMN reports no pertinent disclosures. MGZ reports consulting for Curis, Ikena, Takeda, GlaxoSmithKline (GSK), and Novocure; has received research funding from the Department of Defense, the National Institutes of Health, Medimmune, GSK, Epizyme, Polaris, Sellas Life Sciences, Bristol-Myers Squibb, Takeda, Curis, Atara, and Precog; has received honoraria from CME Medscape, PER, and Research to Practice; and is chair of the board of directors for the Mesothelioma Applied Research Foundation (uncompensated).
